Get started
Work

Safety and Efficacy of Decitabine Plus Ipilimumab in Relapsed or Refractory MDS/AML in the Post-BMT or Transplant Naïve Settings

Year: 2020
Type: article
Source: Blood
DOI: 10.1182/blood-2020-136235
Authors: Jacqueline S. Garcia, Yael Flamand, Benjamin K. Tomlinson, Michael Keng, Lourdes M. Mendez, Samer Khaled, Asad Bashey, Andrew M. Brunner, Alexandra Savell, Donna Neuberg, Ilene Galinsky, Marlise R. Luskin, David P. Steensma, Martha Wadleigh, Eric S. Winer, David E. Avigan, Nicole Cullen, Scott Rodig, Livius Penter, R. Coleman Lindsley, Stephanie Andrews, Matthew S. Davids, Catherine J. Wu, Richard M. Stone, Daniel J. DeAngelo, Robert J. Soiffer
Institutions: Dana-Farber Cancer Institute, Case Western Reserve University, University of Virginia, Beth Israel Deaconess Medical Center, Harvard University, City Of Hope National Medical Center, City of Hope, BMT Group (United States), Massachusetts General Hospital, Brigham and Women's Hospital
Language: English
Subfield: Hematology
Field: Medicine
Open Access status: closed
OpenAlex ID: W3096791018
FWCI: 1.345
Cites:
Cited by: 10
Related to: 10